PRIA Logo™
CaliforniaSB 6462025-2026 Regular SessionSenateWALLET

Prenatal vitamins.

Sponsored By: Akilah Weber Pierson (Democratic)

Signed by Governor

Your PRIA Score

Score Hidden

Personalized for You

How does this bill affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Bill Overview

Analyzed Economic Effects

2 provisions identified: 2 benefits, 0 costs, 0 mixed.

Clear heavy metal info on prenatal vitamins

Beginning January 1, 2027, brand owners must post, on one web page per lot, the name and level of each heavy metal, the Supplement Facts, and a short health statement. The page must be public for the product’s shelf life plus one month and must not require a UPC, lot number, or proof of purchase. It must include details to identify the product, like the name, UPC, size, and lot numbers, and a link to the FDA page on heavy metals. Any webpage that describes the product must show a prominent line that links to the test results. For items shipped to stores on or after January 1, 2027, the outer package must include a line that points to the web address with the required info. For items sold online and shipped to consumers on or after that date, the product page must include the same line with a live link. Starting January 1, 2030, it is illegal to sell or make prenatal vitamins in California if they lack these package or online statements.

Heavy metal testing for prenatal vitamins

Beginning January 1, 2027, makers of bulk or packaged prenatal vitamins sold in California must test a representative sample of each lot for arsenic, cadmium, lead, and mercury. Tests must be done by a lab accredited under ISO/IEC 17025:2017, using methods as sensitive as FDA guidance, and the lab must prove it can measure each metal at 10 μg/kg with a z‑score within ±2. Makers and brand owners must give test results to a state agent when asked. It is unlawful to sell or make prenatal vitamins in California that do not follow these testing rules.

Sponsors & Cosponsors

Sponsor

  • Akilah Weber Pierson

    Democratic • Senate

Cosponsors

There are no cosponsors for this bill.

Roll Call Votes

All Roll Calls

Yes: 216 • No: 0

Senate vote • 9/13/2025

Item 163 — Senate SFLOOR

Yes: 34 • No: 0

House vote • 9/13/2025

Item 36 — Assembly AFLOOR

Yes: 77 • No: 0

legislature vote • 8/29/2025

Vote in CX25

Yes: 15 • No: 0

legislature vote • 7/15/2025

Vote in CX05

Yes: 5 • No: 0

legislature vote • 7/1/2025

Vote in CX08

Yes: 15 • No: 0

Senate vote • 5/28/2025

Item 185 — Senate SFLOOR

Yes: 38 • No: 0

legislature vote • 5/23/2025

Vote in CS61

Yes: 6 • No: 0

legislature vote • 5/12/2025

Vote in CS61

Yes: 7 • No: 0

legislature vote • 4/30/2025

Vote in CS64

Yes: 8 • No: 0

legislature vote • 4/2/2025

Vote in CS60

Yes: 11 • No: 0

Actions Timeline

  1. Chaptered by Secretary of State. Chapter 602, Statutes of 2025.

    10/11/2025Senate

  2. Approved by the Governor.

    10/11/2025legislature

  3. Enrolled and presented to the Governor at 2 p.m.

    9/23/2025legislature

  4. Assembly amendments concurred in. (Ayes 34. Noes 0. Page 3058.) Ordered to engrossing and enrolling.

    9/13/2025Senate

  5. In Senate. Concurrence in Assembly amendments pending.

    9/13/2025Senate

  6. Read third time. Passed. (Ayes 77. Noes 0. Page 3442.) Ordered to the Senate.

    9/13/2025House

  7. Joint Rule 61(a)(14) and 51(a)(4) suspended. (Ayes 59. Noes 20. Page 3413.)

    9/13/2025House

  8. Joint Rule 61(a)(13) suspended. (Ayes 60. Noes 20. Page 3128.)

    9/9/2025House

  9. Ordered to third reading.

    9/9/2025House

  10. Read third time and amended.

    9/9/2025House

  11. Ordered to third reading.

    9/5/2025House

  12. Read third time and amended.

    9/5/2025House

  13. Assembly Rule 69(b)(1) suspended.

    9/5/2025House

  14. Read second time. Ordered to third reading.

    9/2/2025House

  15. From committee: Do pass. (Ayes 15. Noes 0.) (August 29).

    8/29/2025House

  16. August 20 set for first hearing. Placed on APPR. suspense file.

    8/20/2025House

  17. From committee: Do pass and re-refer to Com. on APPR. (Ayes 5. Noes 0.) (July 15). Re-referred to Com. on APPR.

    7/16/2025House

  18. From committee with author's amendments. Read second time and amended. Re-referred to Com. on E.S & T.M.

    7/10/2025House

  19. Read second time and amended. Re-referred to Com. on E.S & T.M.

    7/7/2025House

  20. From committee: Do pass as amended and re-refer to Com. on E.S & T.M. (Ayes 15. Noes 0.) (July 1).

    7/3/2025House

  21. From committee with author's amendments. Read second time and amended. Re-referred to Com. on HEALTH.

    6/16/2025House

  22. Referred to Coms. on HEALTH and E.S & T.M.

    6/5/2025House

  23. In Assembly. Read first time. Held at Desk.

    5/28/2025House

  24. Read third time. Passed. (Ayes 38. Noes 0. Page 1305.) Ordered to the Assembly.

    5/28/2025Senate

  25. Read second time. Ordered to third reading.

    5/23/2025Senate

Bill Text

  • Chaptered

    10/11/2025

    HTML

  • Enrolled

    9/18/2025

    HTML

  • Amended Assembly

    9/9/2025

    HTML

  • Amended Assembly

    9/5/2025

    HTML

  • Amended Assembly

    7/10/2025

    HTML

  • Amended Assembly

    7/7/2025

    HTML

  • Amended Assembly

    6/16/2025

    HTML

  • Amended Senate

    4/10/2025

    HTML

  • Amended Senate

    3/24/2025

    HTML

  • Introduced

    2/20/2025

    HTML

Related Bills

Back to State Legislation